Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1972 Jul;11(3):469–474.

Lymphocyte-monocyte defect associated with anergy and recurrent infections

J S Louie, L S Goldberg
PMCID: PMC1553670  PMID: 4625400

Abstract

Mechanisms of cellular immunity were studied in an anergic female with recurrent bacterial infections. Lymphocytes transformed and produced cytotoxin in the presence of phytohaemagglutinin, but elaborated only migration inhibitory factor (MIF) in response to specific antigen. Monocytes isolated from the patient's peripheral blood were unresponsive to autologous MIF and to homologous MIF from two of three healthy adults. Humoral immunity, complement and neutrophil bactericidal activity were intact. The lymphocyte-monocyte defects found in this patient suggest that they were responsible for the anergy and predisposition to bacterial infections.

Full text

PDF
469

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bendixen G., Soborg M. A leucocyte migration technique for in vitro detection of cellular (delayed type) hypersensitivity in man. Dan Med Bull. 1969 Jan;16(1):1–6. [PubMed] [Google Scholar]
  2. Bennett W. E., Cohn Z. A. The isolation and selected properties of blood monocytes. J Exp Med. 1966 Jan 1;123(1):145–160. doi: 10.1084/jem.123.1.145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bloom B. R., Bennett B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science. 1966 Jul 1;153(3731):80–82. doi: 10.1126/science.153.3731.80. [DOI] [PubMed] [Google Scholar]
  4. David J. R. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci U S A. 1966 Jul;56(1):72–77. doi: 10.1073/pnas.56.1.72. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Goldberg L. S., Bluestone R., Barnett E. V., Landau J. W. Studies on lymphocyte and monocyte function in chronic mucocutaneous candidiasis. Clin Exp Immunol. 1971 Jan;8(1):37–43. [PMC free article] [PubMed] [Google Scholar]
  6. Goldberg L. S., Louie J. S., Baker M. H. Inhibition of macrophage migration: a test system using human monocytes. J Immunol. 1971 Sep;107(3):906–909. [PubMed] [Google Scholar]
  7. Granger G. A., Williams T. W. Lymphocyte cytotoxicity in vitro: activation and release of a cytotoxic factor. Nature. 1968 Jun 29;218(5148):1253–1254. doi: 10.1038/2181253a0. [DOI] [PubMed] [Google Scholar]
  8. Huber H., Fudenberg H. H. Receptor sites of human monocytes for IgG. Int Arch Allergy Appl Immunol. 1968;34(1):18–31. doi: 10.1159/000230091. [DOI] [PubMed] [Google Scholar]
  9. Junge U., Hoekstra J., Wolfe L., Deinhardt F. Microtechnique for quantitative evaluation of in vitro lymphocyte transformation. Clin Exp Immunol. 1970 Sep;7(3):431–437. [PMC free article] [PubMed] [Google Scholar]
  10. Mackaness G. B. The influence of immunologically committed lymphoid cells on macrophage activity in vivo. J Exp Med. 1969 May 1;129(5):973–992. doi: 10.1084/jem.129.5.973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Mackaness G. B. The monocyte in cellular immunity. Semin Hematol. 1970 Apr;7(2):172–184. [PubMed] [Google Scholar]
  12. Thor D. E., Jureziz R. E., Veach S. R., Miller E., Dray S. Cell migration inhibition factor released by antigen from human peripheral lymphocytes. Nature. 1968 Aug 17;219(5155):755–757. doi: 10.1038/219755a0. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES